Blog Post

Blog Post

World Muscle Society Roundup: Clinical Trial Results of Treatments in Development for DMD, XLMTM, SMA, and Pompe Disease

By Jeanene Swanson | October 31, 2019
Blog Post

Reata Pharmaceuticals Announces Positive Results from Pivotal Study of Omaveloxolone in FA

By Jeanene Swanson | October 30, 2019
Blog Post

Capricor Therapeutics Announces Positive Interim Results from Phase 2 Study of CAP-1002 to Treat DMD

By Jeanene Swanson | October 29, 2019
Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

By Jeanene Swanson | October 25, 2019
Blog Post

Reporting Back from the MDA Public Policy and Advocacy Conference — and Keeping Up the Momentum

By Chris Anselmo | October 24, 2019
Blog Post

Five Questions with DMD Researcher Matthew Wood

By Jeanene Swanson | October 23, 2019
Blog Post

ReveraGen Presents Positive Interim Results from Phase 2 Extension Study of Vamorolone to Treat DMD in Young Boys

By Jeanene Swanson | October 21, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019
Blog Post

Clinical Trial Alert: Momenta Pharmaceuticals Seeks Participants for a Phase 2 Myasthenia Gravis Study

By MDA Staff | October 15, 2019
Blog Post

Casey’s General Stores Round Up for MDA

By MDA Staff | October 15, 2019